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Abstract
Background
Thelper1 (Th1) lymphocytes have been previously implicated in atherosclerotic plaque
growth but their role in plaque vulnerability to rupture is less clear. We investigated whether
T-bet knockout that prevents Th1 lymphocyte differentiation modulates classical (M1) mac-
rophage activation or production of matrix degrading metalloproteinases (MMPs) and their
tissue inhibitors, TIMPs.
Methods & Results
We studied the effect of T-bet deletion in apolipoproteinE (ApoE) knockout mice fed a high
fat diet (HFD) or normal chow diet (ND). Transcript levels of M1/M2 macrophage polariza-
tion markers, selected MMPs and TIMPs were measured by RT-qPCR in macrophages iso-
lated from subcutaneous granulomas or in whole aortae. Immunohistochemistry of aortic
sinus (AS) and brachiocephalic artery (BCA) plaques was conducted to quantify protein
expression of the same factors.
Deletion of T-bet decreased mRNA for the M1 marker NOS-2 in granuloma macro-
phages but levels of M2 markers (CD206, arginase-1 and Ym-1), MMPs-2, -9, -12, -13, -14
and -19 or TIMPs-1 to -3 were unchanged. No mRNA differences were observed in aortic
extracts from mice fed a HFD for 12 weeks. Moreover, AS and BCA plaques were similarly
sized between genotypes, and had similar areas stained for NOS-2, COX-2, MMP-12 and
MMP-14 proteins. T-bet deletion increased MMP-13, MMP-14 and arginase-1 in AS pla-
ques. After 35 weeks of ND, T-bet deletion reduced the size of AS and BCA plaques but
there were no differences in the percentage areas stained for M1 or M2 markers, MMPs-12,
-13, -14, or TIMP-3.
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Conclusions
Absence of Th1 lymphocytes is associated with reduced plaque size in ApoE knockout
mice fed a normal but not high fat diet. In either case, M1 macrophage polarization and
expression of several MMPs related to plaque instability are either maintained or increased.
Introduction
Atherosclerosis and in particular plaque rupture underlie myocardial infarctions and strokes,
which remain the greatest cause of mortality in developed countries, and are increasing in prev-
alence worldwide (https://apps.who.int/infobase/mortality.aspx). Atherosclerosis is a slowly-
progressing, chronic inflammatory disease that is initiated by deposition of cholesterol-rich
lipoproteins in the artery wall. Modification of these lipids then leads to production of cyto-
kines and chemokines that recruit monocytes, which differentiate into macrophages under the
influence of colony stimulating factors (CSFs) [1]. Mature macrophages express a variety of
scavenger receptors that promote lipid uptake leading to the formation of foam cell macro-
phages (FCMs). The key role of macrophages in atherosclerosis is demonstrated by their abun-
dance in human plaques (mostly as FCMs) and by the dramatic reduction in atherosclerosis
after genetic [1] or pharmacological [2] deletion of macrophages in mice. Modified lipids can
stimulate the innate immune system into producing cytokines, pathogen associated molecular
patterns and other alarmins that together promote classical macrophage activation [3]. Classi-
cally activated (otherwise known as M1) macrophages produce high levels of toxic reactive
oxygen intermediates, including nitric oxide (NO), by upregulating the inducible nitric oxide
synthase, NOS-2. They also generate pro-inflammatory prostaglandins through cyclooxygen-
ase-2 (COX-2). Moreover, M1 macrophages overexpress several matrix metalloproteinases
(MMPs) that are directly implicated in plaque rupture [4]. Amongst these, collagenases may be
particularly important because they degrade the strength-giving component of fibrous plaque
caps [5]. Classically activated macrophages over-expressing the M1-related MMPs are abun-
dant in the vulnerable shoulder regions of human atherosclerotic plaques [4]. Finally, several
factors that reduce morphological surrogates of plaque instability (notably knockout of CD40
ligand [6]) also decrease markers of classical activation in mouse plaques. Strategies that would
reduce or reverse M1 polarization might therefore prevent plaque ruptures and reduce the inci-
dence of myocardial infarctions.
New epitopes generated by lipid modification can also trigger the adaptive immune system;
there is an impressive volume of experimental evidence that innate and adaptive immune sys-
tems cooperate in perpetuating plaque progression [7]. For example, T-lymphocytes are pres-
ent in atherosclerotic plaques at all stages in humans [8, 9] and rodents [10, 11], with CD4
+ Thelper (Th)-lymphocytes more abundant than CD8+ cytotoxic T-cells [12]. Furthermore,
T-cell clones reactive against relevant antigens, including native and modified lipoproteins [13]
and heat shock protein 60 [14], have been isolated from human plaques. In consequence,
immunomodulation has been the subject of preclinical studies and clinical trials as a way to
reduce atherosclerosis [15]. On the other hand, Rag-1 or Rag-2 gene deletion, which depletes
all T- and B-lymphocytes has little influence on plaque progression in susceptible mice strains,
especially in the presence of a high fat diet (HFD) [16]. Furthermore, the percentage of FCMs
expressing M1 marker genes, MMPs and TIMPs is also unaffected by Rag-1 knockout [16].
However, these results might arise because opposing stimulatory and inhibitory actions of dif-
ferent T- and B-cell subsets lead to a neutral response overall.
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3.
CD4+ T-lymphocytes are categorized into subsets according to their functions and the spec-
trum of cytokines they produce [17]. For example, Th1 cells can promote classical macrophage
activation partly by producing interferon-γ (IFNγ), whereas Th2 cells down regulate Th1-me-
diated responses and provoke allergy, in part through secreting interleukin (IL)-4, -5, -10 and
-13 [18]. T-cell mediated immune responses in atherosclerosis are believed to be Th1 domi-
nated, based on evidence that IFNγ but not IL-4 is abundant in human plaques [19]. Severe
hypercholesterolemia is also associated with a Th1/Th2 switch in T-lymphocytes isolated from
atherosclerosis-susceptible ApoE knockout (EKO) mice [20]. A role for Th1 cells in promoting
atherosclerosis has been inferred because mice that are deficient in either IFNγ receptors [21]
or IFNγ itself [22, 23] have smaller lesions, whereas administration of exogenous IFNγ to EKO
mice augments atherosclerosis [24]. Differentiation of each of the Th-lymphocyte subsets is
orchestrated by a distinct master regulator transcription factor [25]. Specifically, T-bet medi-
ates IFNγ production from CD4+ T-cells [26, 27] and dendritic cells [28], which promotes Th1
and suppresses Th2 differentiation. T-bet deficiency decreases the size of diet-induced atheroscle-
rotic plaques in male, low density lipoprotein receptor (LDLR) deficient mice [29], which further
supports the role of Th1 lymphocytes in lesion progression. However, its role in plaque destabili-
zation and rupture is less clear. T-bet deficiency does not change the proportion of macrophages
in plaques from LDLR deficient mice; and although it decreases the proportion of smooth muscle
cells, this may simply reflect the less advanced state of plaque development [29].
To come to a definite conclusion whether Th1 lymphocytes contribute to M1 macrophage
activation and plaque destabilization in vivo [30], we investigated the impact of T-bet deletion
on M1 and M2 polarization markers and MMP/TIMP production in FCMs from EKOmice.
We studied steady-state mRNA levels in FCMs isolated from subcutaneous granulomas and in
the whole aortae of mice fed a HFD. We also examined advanced plaques in the aortic sinus
(AS) and brachiocephalic artery (BCA) using histological morphometry in mice fed a HFD or
normal chow diet (ND).
Materials and Methods
Breeding of ApoE/T-bet double knockout mice and harvesting of tissues
ApoE knockout mice (B6.129P2-Apoetm1Unc/J) and T-bet knockout mice
(B6.129S6-Tbx21tm1Glm/J) on a C57Bl6 background were purchased from The Jackson Labora-
tory and mated together. The doubly heterozygous progeny were inter-crossed to generate
double knockout T-bet-/-ApoE-/- (DKO) mice and T-bet+/+ApoE-/- (EKO) controls. Genotypes
were confirmed via PCR: tail or ear tissue from each mouse was digested overnight in Direct
PCR-tail solution (Bioquote, UK) and proteinase K (Sigma, UK). PCR was performed on the
digested tissue using Crimson Taq Pol (New England Biolabs, UK) with dNTPs from Bioline
(UK) and primers designed by The Jackson Laboratory (Table 1).
Mice were either fed a normal chow diet (ND: 3.5% fat, LabDiet UK) until 35 weeks old or
were given a high-fat diet (HFD: 21–23% fat, Special Diet Services, UK) for 12 weeks starting at
5 weeks of age. The mice were given an overdose of halothane (to prevent monocyte/macro-
phage mobilisation) and their tissues were harvested either immediately or after perfusion with
phosphate buffered saline (PBS) followed by 10% formalin/PBS (v/v) at physiological pressure.
Tissues harvested included tail (for genotyping), blood (cardiac puncture), spleen, thymus,
liver, heart (for AS), BCA, the entire aorta and peritoneal macrophages (PBS lavage). A further
set of mice were fed the HFD from 6 to 12 weeks of age and used to generate sponge FCM in
vivo (see section: Generation and isolation of FCMs from subcutaneous sponges).
The housing and care of all animals and procedures used in these studies was in accordance
with and under license of the Animals (Scientific Procedures) Act 1986 (London, United
T-Bet KO and Macrophage Polarization in Atherosclerosis
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Kingdom), and conform to the Guide for the Care and Use of Laboratory Animals published
by the U.S. National Institutes of Health (Publication No. 85–23, revised 1996). The study
received local institutional review board (University of Bristol, Bristol, United Kingdom)
approval. The mice were bred and maintained by the University of Bristol Animal Services
Unit, and kept in isolators or scantainers and given sterile food and water ad libitum.
Peripheral blood mononuclear cell (PBMC) isolation and differentiation
Pooled peripheral blood was collected by cardiac puncture from C57Bl6 mice with heparin as
anti-coagulant and diluted with PBS without calcium and magnesium (Lonza, UK) (ratio 1:1).
The diluted samples were subjected to density gradient separation on Ficoll Paque Plus (GE
Healthcare Life Sciences, UK) and centrifuged. After centrifugation the PBMC layer was col-
lected and washed in Hank's Balanced Salt Sodium (HBSS) with phenol red without calcium
and magnesium (Lonza). Non-adhered mouse monocytes were positively selected from PBMC
preparations using CD11b conjugated magnetic beads (Miltenyi Biotec, UK) according to the
manufacturer’s instructions. The CD11b selected monocyte suspension was spun and the pellet
re-suspended in fresh media and counted. To differentiate blood-derived monocytes into macro-
phages, PBMCs were re-suspended in RPMI 1640 media (Life Technologies, UK) supplemented
with antibiotics, glutamine and 10% foetal calf serum (FCS, Invitrogen, UK) and placed in 6-well
culture plates (at 5x105 cells/well) and 12-well culture plates (2.5x105 cells/well). After 2 h the
plates were washed in RPMI/FCS to remove non-adherent cells. The remaining adherent mono-
cytes were cultured for 6–7 days with RPMI/FCS in the presence of 40 ng/ml recombinant
mouse M-CSF (Miltenyi Biotec), allowing the cells to differentiate into macrophages. At this time
the cells were exposed to selected growth factors for 18 h (in FCS free media), as specified in the
text. These included mouse IFNγ at 20 ng/ml (Miltenyi Biotec) and human tissue necrosis factor-
α (TNFα) at 10 ng/ml (R&D Systems, USA). Human cytokines were used only when their effi-
cacy on mouse cells had been previously documented by the suppliers.
Assays on blood samples
Blood was taken via cardiac puncture and heparinized plasma was subsequently analysed for
total, HDL and LDL/VLDL cholesterol (Cholesterol/Cholesterol Ester Quantification Kit,
Abcam, UK), based on the manufacturer’s instructions. The levels of selected M1 and M2 cyto-
kines were assessed in additional samples of mouse plasma using a Bio-Plex Pro Mouse Cyto-
kine Th1/Th2 Panel 8-plex assay (Bio-Rad, USA), according to manufacturer’s instructions.
Generation and isolation of FCMs from subcutaneous sponges
Mice were given the HFD from 6 weeks of age. Two weeks later and under isoflurane anaesthe-
sia 0.5 cm3 sterile polyurethane sponges (Merck, UK) containing ~50 μL Matrigel (VWR, UK)
Table 1. Genotyping primers.
Primer Name Primer Sequence
ApoE Common GCCTAGCCGAGGGAGAGCCG
ApoE WT TGTGACTTGGGAGCTCTGCAGC
ApoE KO GCCGCCCCGACTGCATCT
T-bet Common GCGCGAAGGGGCCACCAAAGAACGGAG
T-bet WT GACTGAAGCCCCGACCCCCACTCCTAAG
T-bet KO TGGGCATACAGGAGGCAGCAACAAATA
doi:10.1371/journal.pone.0148873.t001
T-Bet KO and Macrophage Polarization in Atherosclerosis
PLOS ONE | DOI:10.1371/journal.pone.0148873 February 17, 2016 4 / 28
were placed under the dorsal skin to generate FCMs, as described previously [31, 32]. Bupre-
norphine analgesic was given, and the mice were fed the HFD for a further 4 weeks before they
were sacrificed using an anaesthetic overdose. Freshly recovered sponges were treated with
0.75 mL undiluted dispase (BD Biosciences, USA) and then squeezed to obtain a cellular exu-
date. FCMs were purified using density centrifugation on a metrizamide gradient (1.3507
refractive index, Sigma, UK) and differential adherence, as previously described [33]. Sponge
FCMs were lysed immediately for RNA or protein extraction or left to adhere onto glass cover-
slips where their proliferative capacity was assessed via BrdU incorporation.
BrdU immunocytochemistry (purified and cultured FCMs)
Isolated FCMs from sponges were left to adhere to coverslips overnight at 37°C. BrdU (Sigma)
was added to the cultures for 8 h. The cells were then fixed with 4% paraformaldehyde in PBS
(10 min at room temperature) and permeabilised with 2M HCL (30 min at 37°C) before they
were incubated with anti-BrdU antibody (Sigma) at 4°C overnight. Following a PBS wash, cells
were incubated with biotinylated antibody (DAKO, UK) followed by extravidin-HRP (Sigma)
(30 min each at room temperature). Finally, signal was developed with 3,30-diaminobenzidine
(DAB) (Sigma).
RNA extraction, reverse transcription and quantitative PCR
Purified FCMs were lysed in RLT solution (Qiagen Ltd, UK) with β-mercaptoethanol and total
RNA was extracted using the Qiagen RNeasy kit (Qiagen Ltd), according to the manufacturer’s
instructions. The quantity and quality of resulting RNA was assessed using a NanoDrop ND-
1000 spectrophotometer (LabTech International, UK). A total of 100–200 ng of RNA per sam-
ple was next reverse transcribed to cDNA using QuantiTect Reverse Transcription Kit (Qiagen
Ltd), according to the manufacturer’s instructions. cDNA was amplified via real time quantita-
tive PCR performed on Light Cycler 1.5 (Roche, UK), using the QuantiTect1 SYBR1 Green
PCR Kit (Qiagen Ltd). Most primers used were designed in-house (Table 2) and synthesized by
Sigma. Copy numbers of gene transcripts per total ng RNA input were calculated using stan-
dard curves constructed from purified amplicons, with the exception of measurements in
spleen and liver extracts, where the data are expressed as a percentage of 36B4 (housekeeping
gene) expression.
Flow cytometry
Peritoneal fluid was collected from EKO and DKOmice immediately after sacrificing the ani-
mals; using a lavage of 10 mL of sterile PBS. The cellular components were isolated by centrifu-
gation (1500 rpm, 5 min at 4°C) and red blood cells were lysed using ACK Lysis Buffer
(Invitrogen, UK). Remaining cells were resuspended in cold PBS, counted and approximately
1x106 cells/sample assessed for viability, using a 30 min incubation with Viability Dye
(eFluor780, 1:1000 diluted in PBS; eBioscience, USA) at 4°C. Cells were subsequently washed
with FACS Buffer [25 mMHEPES, 2 mM EDTA, 0.5% v/v FBS in PBS] and non-specific anti-
body binding sites were blocked by incubation with TrueStain fcX (BioLegend, USA) (contain-
ing anti-mouse CD16/32 antibodies mix) for 10 min at 4°C. A freshly prepared mixture of
probe-conjugated antibodies (Table 3) was added to each sample. Following 1 h incubation of
the primary antibodies (Table 3), cells were washed with FACS buffer and streptavadin-488 to
bind to biotinylated F4/80 (1:500 in PBS for 10 min on ice in the dark). Finally, cells were
washed once again in FACS buffer and fixed with 1% paraformaldehyde in FACS buffer. To
each run, we included a viability dye control (using pooled cells exposed to viability dye only
prior to fixation), an unstained control (using pooled cells that were only incubated with
T-Bet KO and Macrophage Polarization in Atherosclerosis
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Table 2. Primer sequences used for quantitative RT-PCR.
Gene Name Primer Sequence
NOS-2 CTCATGACATCGACCAGAAGCGT
TATATTGCTGTGGCTCCCATGTTG
COX-2 ATACTGGAAGCCGAGCACCTTTGG
ATGGTGGCTGTTTTGGTAGGCTGT
Arg-1 AGTCTGGCAGTTGGAAGCATCTCT
TTCCTTCAGGAGAAAGGACACAGG
Ym-1 CAGGTCTGGCAATTCTTCTG
GTCTTGCTCATGTGTGTAAGTG
CD206 CCATTTATCATTCCCTCAGCAAGC
AAATGTCACTGGGGTTCCATCACT
MMP-2 GGCTGACATCATGATCAACTTTGG
GCCATCAGCCGTTCCCATACTTTAC
MMP-3 GCATCCCCTGATGTCCTCGTGG
TCCCCGGAGGGTGCTGACTG
MMP-8 TGCCTCGATGTGGAGTGCCTGA
GCCCTTGACAGCTGTGGCGT
MMP-9 AGAGAGGAGTCTGGGGTCTGGTTT
GAGAACACCACCGAGCTATCCACT
MMP-12 AATTACACTCCGGACATGAAGCGT
GGCTAGTGTACCACCTTTGCCATC
MMP-13 ATGATGATGAAACCTGGACAAGCA
ATAGGGCTGGGTCACACTTCTCTG
MMP-14 ACCACAAGGACTTTGCCTCTGAAG
CACCGAGCTGTGAGATTCCCTTGA
MMP-19 GATGAACTGGCCAGAACTGACCTT
GTCCCCGGTTGATGAGTTAGTGTC
MMP-23 CAAGGTTGGTGAGAGAGGGTAGGA
AGGAGTAGGTGCTGAGAACACGCT
MMP-25 CTCTGAGTGGCAGTGTTTGGAAGA
TGATGTCAGGCTCCTGGTACTGAG
TIMP-1 AGGAACGAAATTTGCACATCAGT
CAAAGTGACGGCTCTGGTAGTCCT
TIMP-2 GACTCCCCCTCAGACTCTCCCTAC
CATATTGATACCACCGCACAGGAA
TIMP-3 CACATCAAGGTGCCATTCAGGTAG
GTTCTCTCCTCCTCAACCCAAACA
36B4 GCCCAGGGAAGACAGGGCGA
gcgcatcatggtgttcttgccca
IFNγ TGCCAAGTTTGAGGTCAACAACCC
TTTTCCGCTTCCTGAGGGTGGATT
Sort1 TGTGGCCAAGCAGCCATCCG
TCAGGCTGCTCCACGCACTC
TNFα CCTGTAGCCCACGTCGTAG
GGGAGTAGACAAGGTACAACCC
GM-CSF ATGCCTGTCACGTTGAATGAAGAG
GGCTGTCTATGAAATCCGCATAGG
IL1β GCAACTGTTCCTGAACTCAACT
(Continued)
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TrueStain fcX prior to fixation) and single stained controls for compensation (see next para-
graph). We used a BD Biosciences flow cytometer (LSR II) with laser lines set to 405 nm, 488
nm and 633 nm. Optical emission filters used for the corresponding fluorescent reagents were
AF488: 530/30 BP, PacBlue: 450/50 BP, AF700: 710/40, PE: 575/26, NIR L/D: 780/60. Data
were analysed using the software package FACS Diva 6.1.2. The possibility of instrument-
related fluorescence intensity changes over time was excluded by daily run quality control pro-
cedures (using CS&T software) and appropriate calibrations.
Multi-colour compensation was performed by using OneComp eBeads (eBioscience, 01–
1111) for single-colour controls. We analysed a minimum of 10000 events/sample. Statistical
analysis used the percentage proportion(s) of cells within specific gates rather than fluorescence
intensities. The gating tree was set as follows: A) FCS/SSC—representing distribution of cells
based on size and intracellular composition, respectively, to B) live gate (eFluor780 negative
cells)–representing the fraction of viable cells to C) F480/CD11b double positive cells–represent-
ing mature macrophages to D) stained with CD11c or CD206 (M1/M2markers, respectively).
Histological and immunohistochemical methods
The BCA from each mouse was supported in agar and embedded in paraffin. Sections were cut
at 3 μm intervals from its origin at the aorta, and stained and analysed as described previously
Table 2. (Continued)
Gene Name Primer Sequence
ATCTTTTGGGGTCCGTCAACT
IL2 TGAGCAGGATGGAGAATTACAGG
GTCCAAGTTCATCTTCTAGGCAC
IL6 GTTCTCTGGGAAATCGTGGA
TTCTGCAAGTGCATCATCGT
IL12p40 AGACCAGGCAGCTCGCAGCAAAGCA
GACACATCCCACTCCCACGCTGCC
IL4 GGTCACAGGAGAAGGGACGCC
GCGAAGCACCTTGGAAGCCCT
IL5 CTCTGTTGACAAGCAATGAGACG
TCTTCAGTATGTCTAGCCCCTG
IL10 GCCCCAGGCAGAGAAGCATGGCCC
ACAGGGGAGAAATCGATGACAGCGCC
Ly6C GCAGTGCTACGAGTGCTATGG
ACTGACGGGTCTTTAGTTTCCTT
doi:10.1371/journal.pone.0148873.t002
Table 3. Flow Cytometer Set up.
Instrument BD Biosciences LSR II
Laser Lines 405 488 633
Emission Filters 450/50 530/30 575/26 710/40 780/60
Fluorochromes PacBlue AF488 PE AF700 NIR L/D
Antibody/Probe CD11b-PB F4/80-Biotin (& streptavadin-488) CD206-PE CD11c-AF700 Viability Dye
(eFluor780)
Cat.No
(Supplier)
Biolegend,
101224
AbD Serotec, UK, MCA497B (& Invitrogen
S11223)
Biolegend,
141706
Biolegend,
117320
eBioscience, 65–0865
doi:10.1371/journal.pone.0148873.t003
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[34, 35]. Briefly, the first section after the bifurcation of the BCA from the aorta was cleared
and rehydrated and then stained using Miller’s elastin/van Gieson (EVG) and plaque dimen-
sions were measured using image analysis software (Image Pro, DataCell, UK). The AS from
each mouse was treated and examined in a similar fashion.
For immunohistochemistry (IHC), 3 μm paraffin sections on glass slides were de-waxed and
rehydrated. Endogenous peroxidase activity was blocked by incubating the slides in 3%H2O2 in
PBS. Antigen retrieval was performed using 10 mM citrate buffer pH 6.0 (2x5 min in a microwave
oven). Non-specific epitopes were blocked with 10% goat serum in 1% BSA:PBS and the sections
were subsequently incubated with primary antibodies for smooth muscle cells (α-smooth muscle
actin; SMA), macrophages (Griffonia simplicifolia lectin (GSL) I), NOS-2, COX-2, CD206, Arg-1,
Ym-1, MMP-12, MMP-13, MMP-14 and TIMP-3 (Table 4A) overnight at 4°C. Negative controls
were included in every run, where IgG from the appropriate host animal substituted the primary
antibody. Sections were then washed and incubated with a biotinylated secondary antibody
(Table 4B) followed by Extravidin-HRP (Sigma) and DAB (Sigma). Nuclei were counterstained
using haematoxylin (Sigma). The areas stained with each cell-specific or phenotypic marker or
MMP/TIMPs antibody were determined using the same image analysis software detailed above
and reported as percentage of the total plaque area. The number of buried layers was assessed
manually on sections stained for elastin (EVG) and confirmed on sections stained for SMA.
Aortae from formalin-fixed animals were carefully cleaned of adherent fat and opened lon-
gitudinally in situ. Lipid-rich areas in these vessels were stained with 2% Oil-Red-O (ORO,
Sigma) in isopropanol and digitalised en face. The area occupied by ORO-stained lesions was
determined using NIH ImageJ v1.43 and is expressed as a proportion of the total vessel area.
Statistical methods
All analyses were performed using GraphPad InStat v3.05 (GraphPad Software Inc, USA) or
SPSS v21 (IBM, USA) software. Data were checked for normality (Kolmogorov and Smirnov
normality test). Regression analyses were performed using Pearson’s correlation co-efficient.
Statistical analyses of data were performed using Students t-test, or 1- or 2-way ANOVAs, with
the 1-way ANOVA followed by a Bonferroni or Tukey-Kramer post-test. TheMann-Whitney U-
Table 4. Primary (A) and secondary (B) antibodies and Griffonia simplicifolia Lectin I (GSL).
A Primary Antibody Supplier/Cat. No Type Dilution Used (IHC)/ Final Concentration
GSL I VectorLabs, USA B1215 Lectin 1:100
SMA Dako, M0851 Mm_Mab 1:100
NOS-2 Abcam, UK #ab15323 Rb_PAb 1:75
COX-2 Abcam #ab15191 Rb_PAb 1:100
Arginase-1 Santa Cruz Biotechnology, USA sc-20150 Rb_PAb 1:100
Ym-1/2 StemCell Technologies, Canada #01404 Rb_PAb 1:100
MMP-12 Abcam #ab52897 Rb_MAb 1:50
MMP-13 Abcam #ab39012 Rb_PAb 1:100
MMP-14 Abcam #ab51074 Rb_MAb 1:50
TIMP-3 Abcam #ab39206 Rb_PAb 1:1000
BrdU Sigma, B2531 Mm_Mab 1:500
Rb IgG1 Sigma, I5006 Neg. Control As needed
Mm IgG2a Sigma, M5409 Neg. Control As needed
B Secondary Antibody Supplier/Cat. No Type Dilution Used (IHC)/ Final Concentration
Gt^Mm Dako, E0433 biotinylated 1:300
Gt^Rb Dako, E0432 biotinylated 1:300
doi:10.1371/journal.pone.0148873.t004
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test or logarithmic transformation was used for non-normally distributed data. Normally distrib-
uted data are expressed as arithmetic mean ± SEM. Statistical significance is defined as P<0.05.
Results
Expression of MMPs and TIMPs in mouse macrophages during classical
activation in vitro
To investigate which MMPs and TIMPs are abundantly expressed and may be increased by
classical (M1) activation we conducted experiments on macrophages differentiated from blood
monocytes with M-CSF. Non-adherent blood monocytes only expressed detectable mRNA lev-
els for MMP-8>MMP-9 = MMP-14>MMP-25 (Fig 1). Remarkably, many MMPs were
strongly and significantly induced during differentiation of monocytes to macrophages using
M-CSF (Fig 1). Transcript copy numbers varied widely with MMP-8, MMP-12, MMP-14,
MMP-19, TIMP-1 and TIMP-2 being especially abundant (Fig 1). MCSF-differentiated macro-
phages were then treated with IFNγ, TNFα or the combination to investigate the influence of
M1 activation on MMPs and TIMPs. None of the MMP transcripts was significantly induced
by IFNγ (Table 5). MMP-2, MMP-9, and MMP-14 transcripts were induced to a similar level
by TNFα in the presence or absence of IFNγ (Table 5). The mRNA levels of TIMP-2 were sup-
pressed by TNFα, whereas those of other MMPs and TIMPs were unaffected (Table 5). These
data suggest that a relatively small subgroup of MMPs and TIMPs is regulated by classical mac-
rophage activation in mouse blood monocyte-derived macrophages in vitro.
Characterization of ApoE knockout (EKO) and ApoE/T-bet double
knockout (DKO) mice fed a HFD
To investigate the impact of preventing differentiation of Th1 lymphocytes on plaque develop-
ment, M1/M2 macrophage polarization and MMP and TIMP expression in FCMs we com-
pared homozygous EKO and ApoE/T-bet double knockout (DKO) mice.
Fig 1. Effects on MMP and TIMPmRNA levels of M-CSF-drivenmacrophage maturation in vitro.MMP and TIMPmRNA levels in blood monocytes and
MCSF-differentiated macrophages in vitro. Steady-state mRNA levels were measured by RT-qPCR in undifferentiated, non-adherent, CD11b positively
selected blood monocytes (Monocytes) or monocyte-derived macrophages differentiated in vitro in M-CSF for 7 days (Macrophages). Values are expressed
as mean ± SEM. * P<0.05 (N = 3).
doi:10.1371/journal.pone.0148873.g001
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Lipid profiles
To induce atherosclerosis rapidly, we fed the EKO and DKOmice with HFD for 12 weeks. We
then measured the levels of cholesterol-rich lipoproteins in the plasma. The plasma concentra-
tions of total cholesterol and LDL+VLDL were not different between EKO and DKOmice. How-
ever, HDL cholesterol was increased 2.4-fold in DKOmice (Table 6). Based on the increase in
HDL, DKOmice might be protected from atherosclerosis compared with EKOmice.
Cytokine profiles and splenic levels of Ly6C
The T-bet transcription factor stimulates IFNγ expression and is also induced by IFNγ, a posi-
tive feedback loop that leads to increased IFNγ production and Th1 lymphocyte differentiation
[26]. Nevertheless, we found no difference in mRNA expression of IFNγ in the livers or spleens
of HFD EKO compared to DKO mice (Table 7), which demonstrates that T-bet independent
sources of IFNγ predominate under these conditions. Furthermore, when we measured the
expression of a panel of other cytokines related to Th1 and Th2 lymphocytes, none showed a
significant change in the spleen. In addition, we used a commercially-available multiplex panel
for the same cytokines to measure blood concentrations. Levels of IL-2, IL-4 and IL-5 were too
low and variable to be informative in any set of mice but the other 5 cytokines gave consistent
values (Table 7). IL-10, IL12p70, GM-CSF, IFNγ and TNFα showed no differences between
genotypes after 12 weeks of HFD, consistent with the splenic mRNA data.
Previous research shows that HFD increases the levels of Ly6C plus monocytes in spleens
and their mobilization into the circulation where they provide a source of activated plaque
Table 5. Comparison of MMP and TIMPmRNA levels after treatment with IFNΓ and TNFα compared with untreated controls (copy number per ng
RNA).
Treatment Control (N = 3) IFNγ (N = 3) TNFα (N = 3) IFNγ + TNFα (N = 3)
Gene Mean SEM Mean SEM P value Mean SEM P value Mean SEM P value
MMP-2 53 16 32 20 0.375 195 58 0.014 173 15 0.050
MMP-3 33 17 49 37 0.908 59 34 0.638 25 8 0.929
MMP-8 744 268 733 191 0.746 737 180 0.771 427 109 0.491
MMP-9 56 18 48 19 0.632 404 66 0.016 506 70 0.019
MMP-12 70097 12719 74065 5569 0.713 105010 16959 0.364 67815 25118 0.719
MMP-13 90 44 52 14 0.286 12 1 0.108 5 2 0.074
MMP-14 4286 772 4175 1459 0.773 73506 4461 0.006 79766 3543 0.004
MMP-19 1089 320 1166 115 0.537 1216 169 0.504 591 108 0.238
MMP-23 113 57 120 57 0.920 43 19 0.422 37 17 0.172
MMP-25 18 7 47 5 0.149 106 20 0.079 72 18 0.090
TIMP-1 275 99 279 167 0.861 97 62 0.103 137 55 0.085
TIMP-2 639 184 563 75 0.946 324 79 0.033 411 20 0.407
TIMP-3 4 1 2 2 0.317 0 0 0.070 1 0 0.064
doi:10.1371/journal.pone.0148873.t005
Table 6. Concentration of cholesterol-containing lipids in plasma from HFD EKO and DKOmice.
Cholesterol Lipids EKO 12 wk HFD (N = 7) DKO 12 wk HFD (N = 7)
[mg/dL] Mean SEM Mean SEM P value
TOTAL 1159.1 15.3 1126.9 76.1 0.383
HDL 52.6 8.5 128.2 28.1 0.007
LDL & VLDL 1106.5 19.3 998.7 93.9 0.717
doi:10.1371/journal.pone.0148873.t006
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macrophages [36]. There were, however, no differences between DKO and EKOmice and
hence the effect on Ly6C mRNA levels was independent of T-bet.
Activation status of peritoneal macrophages
To further characterize the effects of T-bet knockout, resident peritoneal macrophages were
collected from EKO and DKOmice fed a HFD for 12 weeks and prepared for flow cytometry,
using antibodies to identify mature macrophages (F4/80 and CD11b) as well as markers of clas-
sical (CD11c) and alternative (CD206) macrophage activation, characterised previously [37].
Mature macrophages positive for both F480 and CD11b were seen in all samples from both
genotypes, comprising approximately 20% of all the cells collected (Fig 2). M1 macrophages
(or indeed any other cell types) positive for CD11c were not detected in either genotype but the
percentage of CD206-positive (M2) macrophages was significantly higher in DKO (19%) than
EKO (5%) mice (Fig 2). The remaining macrophages were negative for both CD11c and
CD206. This confirms previous work indicating that peritoneal macrophages have low levels of
M1 and higher levels of M2 polarization [38, 39]. Moreover, our data indicates that knocking
out T-bet biases macrophage responses towards M2, as expected [28].
Phenotypes of FCMs obtained from subcutaneous granulomas in EKO
and DKOmice fed a HFD
We first investigated the influence of deleting T-bet on the levels of M1 and M2 markers,
MMPs and TIMPs in granuloma FCMs from subcutaneous sponges placed into mice fed a
HFD for 4 weeks. The yield of FCMs purified by flotation (i.e. buoyant density<1) was
2.7 ± 0.41 and 3.0 ± 0.71 x 106 cells per EKO and DKOmouse, respectively. These FCMs abun-
dantly expressed both M1 (NOS-2, COX-2 and IL-6) and M2 (CD206, Arg-1, FIZZ1, IL-10
and Ym-1) macrophage markers (Table 8), consistent with previous work [16, 31, 33].
Amongst the M1 markers, NOS-2 was decreased significantly in DKO vs EKOmice and COX-
2 and IL-6 showed the same trend (Table 8), which provides evidence for polarization away
fromM1 in the absence of Th1 cells. Expression of the M2 markers, Arg-1, CD206, FIZZ1, IL-
10 and Ym-1 was similar in DKO vs EKOmice. Consistent with the effect on NOS-2, TIMP-2
levels, which were decreased by M1 conditions in vitro, were increased in DKO vs EKO mice.
Table 7. mRNA levels and plasma cytokine concentrations in HFD EKO and DKOmice.
Spleen (liver) mRNA [% of 36B4) Plasma cytokine [pg/mL]
Cytokine EKO 12wk HFD
(N = 8)
DKO 12wk HFD
(N = 8)
EKO 12wk HFD
(N = 9)
DKO 12wk HFD
(N = 10)
Mean SEM Mean SEM P value Mean SEM Mean SEM P value
IFNγ (liver) 2.894 0.747 3.674 0.254 0.710
IFNγ 1.006 0.282 0.619 0.371 0.232 10 2.9 15.7 9.2 0.910
TNFα 0.240 0.148 0.138 0.056 0.517 249.3 55.8 448.7 174.5 0.549
GM-CSF 2.058 1.521 1.807 1.768 0.447 124.7 36.6 106.1 24 0.905
IL12p40 5.105 3.763 5.657 4.720 0.161 92 31.9 74.1 18.8 0.968
IL2 0.0052 0.0052 0.0000 0.0000 0.242 44.5 17.4 24.3 13.9 0.447
IL4 0.039 0.009 0.033 0.009 0.574 3.3 1.3 21.7 12.8 0.604
IL5 0.025 0.011 0.063 0.015 0.036 12.5 5.2 76.4 44.1 0.549
IL10 0.076 0.027 0.052 0.036 0.394 33.8 4.7 23.1 4.4 0.211
Ly6C 1.232 1.005 0.312 0.263 0.315
doi:10.1371/journal.pone.0148873.t007
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Fig 2. Flow cytometry of peritoneal fluid macrophages. Flow cytometry of peritoneal fluid macrophages. Viable mature macrophages (F4/80+ and
CD11b+) from peritoneal lavage fluid were subsequently categorized according to their expression of M1 (CD11c+) and/or M2 (CD206) markers. Values are
expressed as mean ± SEM. * P<0.05 (N = 9–10).
doi:10.1371/journal.pone.0148873.g002
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However, of the MMPs that were stimulated by M1 activation in vitro, MMP-2 was paradoxi-
cally increased in EKO vs DKOmice and MMP-14 showed the same trend, whereas MMP-9
showed no difference. Furthermore, pilot experiments using in situ zymography found no dif-
ference in gelatinase activity between foam cells of EKO and DKOmice (results not shown).
Hence, although preventing Th1 cell differentiation reduced M1 polarization in granuloma
FCMs, the levels of MMP mRNAs were not changed or actually increased. FCMs isolated from
subcutaneous granulomas have measureable rates of proliferation [31, 33]. Immunocytochem-
istry after an 8 h BrDU pulse showed a significantly increased proliferation rate in DKO com-
pared to EKO mice (11.45±1.51% vs 6.96±0.74%, N = 8–11, P<0.05).
Transcript levels of M1 and M2 markers, MMPs and TIMPs in whole
aortae from EKO and DKOmice fed a HFD for 12 weeks
Quantitative RT-qPCR of mRNAs extracted from whole aortae from mice fed a HFD for 12
weeks did not reveal any significant differences in M1 or M2 markers, MMPs or TIMP
mRNAs between EKO and DKOmice fed a HFD for 12 weeks (Table 9). This was consistent
with the generation of similar sized atherosclerotic plaques in these aortas (Fig 3).
Atherosclerotic plaque size and composition in EKO vs DKOmice fed a
HFD for 12 weeks
Atherosclerotic lesions develop rapidly after HFD in the aortic sinus (AS) and the aortic arch
[40], especially at the origin of the brachiocephalic artery (BCA) in EKOmice [41]. From histo-
logical sections, plaques in the AS and BCA were not different in DKO and EKOmice (Fig
3A), although there was a trend to smaller plaques in the AS of DKO mice. We also looked at
lesion formation en face using the whole aorta and found no difference between EKO and
DKOmice (Fig 3B). Furthermore, we counted the number of buried fibrous layers in BCA pla-
ques, as a marker of plaque complexity or instability [42]. We found no significant differences
Table 8. Levels of mRNA transcripts (copies per ng of total RNA) in granulomamacrophages.
Gene EKO 12 wk HFD (N = 8) DKO 12 wk HFD (N = 6)
Name Mean SEM Mean SEM P value
NOS-2 69 10 33 11 0.034
COX-2 762 78 576 117 0.193
IL-6 56 8 43 7 0.254
Arg-1 52971 7061 44141 8684 0.441
Ym-1 9 3 11 4 0.618
CD206 2197 521 2227 378 0.965
FIZZ1 440 128 613 164 0.413
IL-10 3539 567 4334 649 0.376
MMP-2 243 34 435 56 0.009
MMP-9 106 17 99 17 0.776
MMP-12 67164 7863 74200 9786 0.581
MMP-13 12836 2273 9767 2197 0.363
MMP-14 2335 301 2905 179 0.162
TIMP-1 1245 168 1529 277 0.374
TIMP-2 6277 605 9213 1321 0.048
TIMP-3 1416 182 1510 177 0.724
doi:10.1371/journal.pone.0148873.t008
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between genotypes, with EKO having 1.5 ± 0.2 buried layers per plaque and DKO having
1.6 ± 0.2 buried layers per plaque (N = 9–11, P = 0.9749).
Griffonia simplicifolia Lectin I (GSL) was used to stain plaque macrophages (Fig 4), the
majority of which appeared to be FCMs. Some medial cells also stained with GSL, previously
identified as foamy vascular SMCs transdifferentiating towards macrophages [43]. However,
the media was not included in our analyses. We found no differences in the percentage of pla-
que area stained for GSL at either site between DKO and EKO mice (Fig 3C). Interestingly, AS
plaques were significantly more macrophage-rich than BCA plaques (approximately 60% vs
45%, respectively). IHC for smooth muscle α-actin (SMA) was used to quantify the presence of
SMCs, which were mainly located in the fibrous cap of plaques, as expected (Fig 4). EKO mice
had approximately 15% of their plaques stained for SMA in either site (Fig 3), consistent with
the expected lipid-rich nature of plaques in this model at this time point. DKO mice had
approximately 2 fold more SMA in their AS plaques and approximately 2 fold less SMA in
their BCA plaques than EKOmice (Fig 3).
M1 and M2 markers, MMP-12, -13 and -14 and TIMP-3 protein
expression in atherosclerotic plaques of EKO vs DKOmice after 12
weeks of HFD
We used IHC to observe and quantify the protein expression of the M1 markers, NOS-2 and
COX-2, and M2 markers, Arg-1 and Ym-1 (Fig 4). We also studied the protein expression of
MMP-12, MMP-13 and MMP-14 and TIMP-3 because of their prominent roles in plaque
growth and stability (see Discussion). The staining was clear and specific (Fig 4) and we mea-
sured the percentage of total plaque that stained with each antibody. Although some of the
antibodies stained cardiac myocytes surrounding the aortic root, this did not affect our quanti-
fication because only areas within plaques were measured.
After 12 weeks of HFD, there was no significant difference in the areas stained for either
NOS-2 or COX-2 in AS or BCA plaques of DKO compared to EKO mice (Fig 5A). Hence it
appears that Th1 lymphocytes are not required for M1 polarization in atherosclerotic plaque
FCMs after 12 weeks of HFD. AS plaques of DKOmice had a significantly increased percentage
area positive for Arg-1 when compared to EKO mice (5.6±2.3 vs 0.9±0.5%, N = 7–10),
Table 9. Levels of mRNA transcripts (copies per ng of total RNA) in extracts of mouse aortae.
Gene EKO 12 wk HFD (N = 9) DKO 12 wk HFD (N = 8)
Name Mean SEM Mean SEM P value
NOS-2 33 12 43 17 0.6318
COX-2 698 159 696 139 0.9927
Arg-1 7 6 8 4 0.8944
Ym1 6 2 8 3 0.5795
MMP-2 650 112 559 114 0.5785
MMP-9 44 7 48 6 0.6746
MMP-12 1937 566 1792 538 0.8562
MMP-13 473 141 377 112 0.6081
MMP-14 3110 447 3107 651 0.9970
MMP-19 410 107 840 228 0.0965
TIMP-1 1123 374 1798 730 0.4078
TIMP-2 8504 1022 8498 876 0.9965
TIMP-3 30193 5493 27460 3997 0.6996
doi:10.1371/journal.pone.0148873.t009
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suggesting increased polarization towards M2, but this was not observed in the BCA (Fig 5A).
Moreover, we observed no significant differences in the percentage of BCA plaque area stained
for Ym-1 between DKO and EKO mice (Fig 5A). Hence there was only weak evidence for
increased M2 polarization of plaque FCMs in the absence of Th1 cells under these conditions.
Staining for MMP-13, which increases on M1 activation, was paradoxically increased by
approximately 2 fold in DKO vs EKO mice at both sites, although the increase was statistically
significant only in AS plaques (P = 0.0090) (Fig 5B). Staining for MMP-14, which is also M1
related, was similarly increased in the AS plaques of DKO vs EKO mice (where P = 0.032).
There were no significant differences between genotypes in MMP-12 or TIMP-3 staining at
either site studied.
Fig 3. Atherosclerotic plaque size and composition after 12 weeks of HFD in EKO vs DKOmice. Plaque size and composition in EKO vs DKOmice fed
a HFD for 12 weeks. (A) AS and BCA plaques were taken from EKO (N = 15) and DKO (N = 10–11) mice. A) Average plaque areas were quantified from the
12 near serial sections subjected to EVG or other cell-specific or other stains. (B) Oil-red-O staining was used to stain for lipids en face and the percentage
area of lipids in whole aortae was quantified (N = 10). Further sections of AS and BCA plaque were stained for the presence of (C) macrophages (GSL I) and
(D) smooth muscle cells (SMA). Values are expressed as mean ± SEM. * P<0.05.
doi:10.1371/journal.pone.0148873.g003
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Comparison of plaques from EKO vs DKOmice fed a normal diet (ND)
for 35 weeks
It was previously shown that deletion of T and B cells had no effect on lesion size in EKO mice
fed a HFD [44, 45] but resulted in a reduced lesion size in mice fed a ND for a longer period
[44, 46]. This led to the concept that the greater inflammatory effect of the HFD could over-
whelm the protective effect of deleting adaptive immunity [47]. To allow for this possible con-
founding effect in our experiments, we also studied EKO and DKOmice fed a ND, under
which conditions plaque development is known to be considerably slower [40]. Following pilot
observations showing small and highly variable plaques in mice fed a ND until 30 weeks of age
(data not shown), we fed EKO and DKOmale mice a ND until 35 weeks of age.
Fig 4. Immunohistological staining for cell type, M1 and M2markers, MMPs-12, -13 and -14 and TIMP-3 after 12 weeks of HFD. Immunohistochemical
staining for cell type, M1/M2 markers, selected MMPs and TIMP-3 after 12 weeks of HFD. Near consecutive sections to the sections stained with EVG were
stained for macrophages (GSL I), smooth muscle cells (SMA), M1 markers (NOS-2 & COX-2), M2 markers (Arg-1 and Ym-1), selected MMPs-12, -13 and -14
or TIMP-3, as indicated. Isotype controls were performed with non-immune IgG replacing the primary antibody in each run. This figure shows stained
sections of AS plaques from an EKOmouse as a representative example.
doi:10.1371/journal.pone.0148873.g004
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Lipid profiles
Terminal plasma LDL plus VLDL concentrations were significantly lower after 35 weeks of ND
compared to 12 weeks of HFD (19%, P = 0.0003 for EKO and 27%, P = 0.0012 for DKO)
(Table 10 compared to Table 6), consistent with previous more extensive observations [40, 48].
However, concentrations of total cholesterol or LDL plus VLDL were not different between
EKO and DKOmice after 35 weeks of ND (Table 10). HDL cholesterol was significantly
increased in DKO compared to EKO mice (by 1.6 fold), as it was in mice fed a HFD (Table 6).
Based on the increase in HDL, DKOmice might be protected from atherosclerosis compared
with EKO mice.
Fig 5. Expression of M1/M2markers and selected MMPs/TIMP-3 in plaques of HFD EKO and DKOmice.Quantification of M1 and M2 markers, MMPs
and TIMP-3 in atherosclerotic plaques of EKO (N = 9–15) and DKO (N = 5–11) mice after 12 weeks of HFD. Near consecutive sections were subjected to IHC
for (A) NOS-2 and COX-2 (as M1 markers), Arg-1 and Ym-1 (as M2markers) and (B) MMPs-12, -13, -14 and TIMP-3. Values are expressed as mean ± SEM.
* P<0.05.
doi:10.1371/journal.pone.0148873.g005
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Cytokine profiles and splenic levels of Ly6C
Consistent with the expected effect of T-bet knockout, we observed a significant reduction in
liver and spleen IFNγmRNA levels in DKO compared to EKO mice fed a ND (Table 11).
Hence, under ND, T-bet dependent sources of IFNγmust predominate. Despite this, the levels
of all the other cytokine mRNAs measured were not different, except IL-2 which was increased
in DKO compared with EKO mice. By contrast to the effects in the spleen and liver, circulating
levels of IFNγ were 20-fold higher in DKO compared to EKO mice, demonstrating that T-bet
independent sources of IFNγ predominate in this compartment. Levels of IL-12p70, GM-CSF
and TNFα, were also approximately 3–20 fold higher in DKO compared with EKO mice
(Table 11). Levels of IL-10, which is associated with Th2 lymphocytes and alternative macro-
phage activation, were also increased approximately 4-fold in DKO compared to EKO mice.
Only the splenic mRNA levels of IL-12p40 were greater between 12 weeks of HFD and 35
weeks of ND (Table 11 compared to Table 7). However, blood levels of IFNγ, TNFα, GM-CSF,
IL-12p70 and IL-10 were significantly lower in EKO mice fed a ND for 35 weeks compared
with those fed a HFD for 12 weeks (all P<0.05) (Table 11 compared with Table 7). This is con-
sistent with previous studies at 12 weeks for both diets, which demonstrates the pro-inflamma-
tory effect of HFD [49].
Splenic levels of Ly6C mRNA were not different on EKO and DKOmice under ND, similar
to the results from HFD.
Plaque size and composition
When EKOmice were fed a ND for 35 weeks, lesions in the AS, BCA and aorta were approxi-
mately the same size as after 12 weeks of HFD (Fig 6A compared with Fig 3A). Both AS and
Table 10. Concentration of cholesterol-containing lipids in plasma from ND EKO and DKOmice.
Cholesterol Lipids EKO 35 wk ND (N = 7) DKO 35 wk ND (N = 7)
[mg/dL] Mean SEM Mean SEM P value
TOTAL 935.9 73.0 794.5 92.8 0.270
HDL 41.9 6.3 65.2 6.5 0.038
LDL & VLDL 894.1 75.4 729.3 90.2 0.218
doi:10.1371/journal.pone.0148873.t010
Table 11. mRNA levels and plasma cytokine concentrations in ND EKO and DKOmice.
Spleen (liver) mRNA [% of 36B4) Plasma cytokine [pg/mL]
Cytokine EKO 35wk ND
(N = 8)
DKO 35wk ND
(N = 8)
EKO 35wk ND
(N = 10)
DKO 35wk ND
(N = 10)
Mean SEM Mean SEM P value Mean SEM Mean SEM P value
IFNγ (liver) 7.075 0.760 9.176 1.881 0.024
IFNγ 0.230 0.102 0.045 0.013 0.004 0.4 0.3 7.6 2.6 0.005
TNFα 0.667 0.150 0.587 0.221 0.645 95.6 10.5 245.5 51.7 0.018
GM-CSF 0.122 0.094 0.035 0.019 0.642 21.1 6.6 115.6 29.9 0.002
IL12p40 0.068 0.026 0.292 0.270 0.442 20.3 3.4 221.3 84.9 0.000
IL2 0.0145 0.0076 0.0549 0.0166 0.028 3.5 0.0 15.1 8.1 0.481
IL4 0.055 0.008 0.035 0.010 0.141 1.5 1.0 7.1 2.9 0.123
IL5 0.024 0.011 0.046 0.032 0.696 7.4 3.2 34.5 14.7 0.218
IL10 0.059 0.015 0.041 0.012 0.302 8.0 2.3 29.8 9.8 0.009
Ly6C 6.309 1.649 4.773 1.607 0.442
doi:10.1371/journal.pone.0148873.t011
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BCA lesions were significantly smaller in DKO compared to EKO mice (Fig 6A), consistent
with previous findings in the AS of LDLR null mice [29]. There were significantly fewer plaques
in the BCA of DKO mice compared with EKO mice after 35 weeks of ND (DKO: 5/10, EKO: 9/
10; Fishers Exact test, P = 0.0426). However, the areas of en face staining in the aorta were simi-
lar in EKO and DKOmice (Fig 6B). There was no significant difference in the percentages of
AS or BCA plaque areas stained for macrophages or SMCs (Fig 6C and 6D). In addition there
was no difference in the number of buried layers per BCA plaque, with EKO having 1.4 ± 0.3
and DKO having 1.5 ± 0.9 (P = 0.8769). Hence, T-bet KO reduced the size but did not affect
the composition of AS or BCA plaques. AS plaques had fewer macrophages than BCA plaques
irrespective of genotype (approximately 20% vs 45% of the plaque area, respectively) (Fig 6C).
Fig 6. Atherosclerotic Plaque Size and composition after 35 weeks of ND in EKO vs DKOmice.Quantification of M1 and M2markers, and MMP-s and
TIMP-3 in atherosclerotic plaques of EKO and DKOmice after 35 weeks of ND. AS and BCA plaques were taken from EKO (N = 6–10) and DKO (N = 3–11)
mice. Near consecutive sections were subjected to IHC for (A) NOS-2, COX-2 (as M1 markers) or Arg-1 and Ym-1 (as M2markers) or (B) MMPs-12, -13, -14
or TIMP-3. Note that 5 of the 10 DKOmice had no plaques in the BCA. Values are expressed as mean ± SEM. * P<0.05.
doi:10.1371/journal.pone.0148873.g006
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Staining for M1 and M2 markers, MMPs-12, -13 and -14 and TIMP-3
There were no significant differences in the areas of AS or BCA plaques stained by M1 or M2
markers between genotypes after 35 weeks of ND (Fig 7A). The comparison for the BCA needs
caution because only five of the DKOmice had any plaque at this site. Arg-1 staining was very
low in the AS of EKO or DKOmice after the 35 weeks of ND (Fig 7A). However, Ym-1 was
measureable and tended to be increased in DKO mice, again providing weak evidence for
increased M2 polarization (Fig 7A). Finally, there were no significant differences in staining
area for MMPs-12, -13, -14 or TIMP-3 between EKO and DKOmice at either site (Fig 7B).
Fig 7. Expression of M1/M2markers and selected MMPs/TIMP-3 in plaques of ND EKO and DKOmice.Quantification of M1 and M2 markers, and
MMP-s and TIMP-3 in atherosclerotic plaques of EKO and DKOmice after 35 weeks of ND. AS and BCA plaques were taken from EKO (N = 6–10) and DKO
(N = 3–11) mice. Near consecutive sections were subjected to IHC for (A) NOS-2, COX-2 (as M1markers) or Arg-1 and Ym-1 (as M2markers) or (B) MMPs-
12, -13, -14 or TIMP-3. Note that 5 of the 10 DKOmice had no plaques in the BCA. Values are expressed as mean ± SEM. * P<0.05.
doi:10.1371/journal.pone.0148873.g007
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Discussion
Main findings
We show here that T-bet knockout decreases plaque size but not composition in ApoE null Bl6
mice fed a ND, but not those fed a HFD. The clear, new message from our study is that T-bet
knockout has no effect onM1macrophage polarization and only marginally increases M2 polari-
zation on either diet. Moreover, T-bet knockout does not reduce and may even increase the
mRNA expression of several MMPs that have been shown to promote plaque development and
act as histological surrogates of instability. Furthermore, T-bet knockout does not increase the
mRNA expression any TIMPs that have been ascribed a protective role in atherosclerosis. These
results were confirmed at protein level for MMPs-12, -13 and -14, which are some of the MMPs
most clearly implicated in plaque progression and instability [50] and also for TIMP-3, which
has a prominent protective role [51, 52]. Given that a major consequence of T-bet deletion is pre-
venting Th1-lymphocyte development, the implication is that reducing Th1 activity will have lit-
tle effect on local macrophage activation in plaques and hence on their vulnerability to rupture.
Myocardial infarction is a prevalent cause of death worldwide, and plaque rupture is the
most common mechanism [53]. Vulnerable plaques have fewer SMCs but more macrophages
and T-lymphocytes than stable plaques. Furthermore, auto-reactive T-cell clones have been
isolated from human plaques and this has led to the hypothesis that Th1-cell driven inflamma-
tion may exacerbate atherosclerosis and promote plaque instability [54]. More specifically, Th1
cells could stimulate macrophages towards an M1 phenotype that not only perpetuates inflam-
mation but also directly reduces plaque stability by expressing increased amounts of extracellu-
lar proteases, including MMPs. However, this hypothesis has not until now been tested
directly. Indeed, the influence of deleting Th1 cells on M1 macrophage polarization and MMP/
TIMP expression has not to our knowledge been previously investigated in any model of
inflammation.
In vitro studies
As a preliminary, we investigated the regulation of a broad range of MMPs and TIMPs in
mouse blood monocyte derived macrophages polarized to M1 with TNFα either in the pres-
ence or absence of IFNγ. We used high concentrations of cytokines and allowed sufficient time
(18 hours) for priming effects to occur. MMPs-2, -9, and -14 were upregulated and TIMP-2
downregulated by M1 polarization with TNFα, consistent with in vitro observations on other
preparations of mouse and human macrophages [16, 55]. MMP-13 was previously shown not
to be upregulated by TNFα [56] in mouse macrophages, consistent with our present data,
although M1 polarization with bacterial lipopolysaccharide was effective [16, 56]. No stimula-
tory effects of IFNγ were observed in our in vitro studies or in previous studies of mouse bone
marrow derived macrophages [16]. In contrast, MMPs-12, -14 and -25 are up-regulated and
TIMP-3 is greatly down-regulated by IFNγ in human monocyte derived macrophages [4]. Pre-
vious studies also indicated that, amongst the mouse genes, only MMP-19 showed significant
up-regulation and none down-regulation under M2 conditions [16]. By comparison, human
MMP-12, MMP-25 and TIMP-3 genes were up-regulated under M2 conditions [4]. Hence
there are clear differences between mouse and human macrophages, although clear limitation
of such in vitro studies is their inability to reflect all possible in vivo conditions.
Plaque size and composition
T-bet deletion has been studied previously in atherosclerosis-prone LDLR KOmice fed a HFD
[29] where a clear reduction in AS plaque size was observed in male but not female mice. For
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this reason we focused our own study on male mice. However, we did not observe a reduction
in plaque size in DKO compared to EKO mice fed a HFD (Fig 3), and considered this might be
owing to the overwhelming effect of the HFD. It was previously shown that deleting all T and B
cells only reduces plaque size in EKO mice under ND and not HFD [44–46]. Consistent with
this, we also observed a reduction in atherosclerosis resulting from T-bet deletion in EKO mice
fed a ND (Fig 6) and this was similar in magnitude to that previously observed in LDLR KO
mice [29]. Indeed the effect was quite dramatic, with half of the mice on ND having no plaque
at all in the BCA. The previous studies in LDLR KOmice [29] reported no effect of T-bet dele-
tion on the macrophage content of plaques but a decrease in SMC content, which was ascribed
to the less advanced stage of these plaques. Our results also showed no difference in macro-
phage content of lesions of EKO and DKOmice either fed a HFD or ND. SMCs appeared
much more abundant overall in EKO plaques after 12 weeks HFD compared to the reported
values from LDLR KOmice [29]. We found a reduction in SMC content in the BCA but there
was an increase in the AS; and no differences were found at either site after 35 weeks of ND.
Hence the effects of T-bet deletion were different depending on the site and dietary conditions.
Interestingly, IFNγ has been shown to stimulate [57] or inhibit [58] proliferation of SMCs in
culture, depending on the conditions. By contrast, T-bet deletion significantly increased prolif-
eration of FCMs isolated from subcutaneous granulomas, consistent with previous results
showing that the Th1-cell derived cytokine, IFNγ, can inhibit macrophage proliferation [59].
Lipid metabolism
Lower blood cholesterol levels have been observed in EKO mice fed a ND compared to a HFD
continuously over 40 weeks of life [40, 48] and our observations at the time of sacrifice were
consistent with these comprehensive time course studies. In their original description of the
effect of T-bet deletion on LDL receptor null mice, Buono and colleagues [29] observed no dif-
ference in total circulating cholesterol levels, similar to our results. However, we also measured
the HDL fraction, which was increased in DKO compared to EKO mice. In addition, Buono
and colleagues [29] noted a significant reduction in total circulating IgG2a levels, and both
IgG1 and IgG2a levels of antibodies to modified LDLs. Furthermore, there was an increase in
serum levels of the EO6 natural antibody against phosphorylcholine. All of these factors may
contribute to the decreased plaque size observed in T-bet DKOmice. Interestingly, we observed
a similar increase in HDL levels in Rag-1 deleted EKO mice that lack both T- and B-lympho-
cytes [16]. Related effects on lipid metabolism of manipulating adaptive immunity have been
recently described. For example, T-bet deletion was shown to increase visceral adiposity but
paradoxically improve insulin sensitivity [60]. Furthermore, depletion of regulatory T cells in
LDLR KO mice caused a variety of gene changes in the liver that led to hypercholesterolaemia
[61]. One of the most prominent of these was an increase in liver sortilin expression [61] and
we found a converse decrease in liver sortilin mRNA expression in DKO compared to EKO
mice (results not shown). Fully defining the mechanisms underlying the complex effects of T-
bet deletion on lipid metabolism would require a separate study beyond the present scope.
Inflammation
There is a now overwhelming evidence from mouse models and humans that high fat feeding
causes systemic inflammation [62]. For example, increases in several pro-inflammatory cyto-
kines and IL-10 were observed in EKO mice fed a HFD compared to a ND for 12 weeks in a
previous study [49]. The greater concentrations of the same cytokines, including IFNγ, TNFα,
GM-CSF, IL-12 and IL-10, that we observed after HFD compared to ND at the point of sacri-
fice (Table 7 compared to Table 11) are consistent with these and other similar findings [48].
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Hence, although our terminal samples were taken at different time points, the differences are
likely to be due to the diets. In our experiments, HFD abolished any differences in blood cyto-
kine levels between EKO and DKOmice, as well as any differences in mRNA expression of
IFNγ and other cytokines in the liver or spleen. T-bet knockout greatly reduces release of IFNγ
from CD4+ T-lymphocytes [29], as well as dendritic cells [28]. However, eomesodermin can
still drive IFNγ production in CD8+ T-cells on T-bet KO mice [63] and other sources of IFNγ,
including monocyte/macrophages themselves might be able to compensate for loss of Th1
cells, as has been shown directly in Rag-1 depleted mice [64], thereby replenishing plasma and
tissue levels. Another inflammatory mechanism by which HFD and immunomodulation can
influence atherosclerosis is through changing the amplitude of circulating monocyte popula-
tions [65], in particular increasing the mobilization of Ly6C positive monocytes from the
spleen [36]. However, we did observe any differences in Ly6C levels in the spleens of our DKO
compared to EKO mice.
Macrophage polarization and MMP/TIMP expression
In T-bet null mice, it was previously shown that splenic and lymph node T-cells produce much
less IFNγ and switch towards production of Th2 cytokines, including IL-4, -5 and -10 [29].
This would be expected to favour M2 polarization of macrophages in response to IL-4 and IL-
10 rather than M1 polarization primed by IFNγ [66]. Our studies of peritoneal macrophages
provided evidence for increased M2 polarization. However, there were no M1 polarized FCMs
in the peritoneum of EKO or DKOmice, which is similar to what was observed in LDLR KO
mice [38]. Our previous studies showed that FCMs obtained from subcutaneous granulomas,
which are subjected to an additional stimulus from the foreign body reaction, express high lev-
els of both M1 and M2 markers genes [16]. The present results confirmed this observation and
extended it to show that, based on levels of NOS-2, T-bet deletion reduced M1 polarization.
We then directly compared the levels of a large range of MMPs and TIMPs in FCMs from sub-
cutaneous granulomas. There was not, however, any measurable reduction in the mRNA levels
of MMP-2, -9 or -14 that could be increased by M1 polarization.
We extended our studies of mRNA levels to whole aortae. After 12 weeks on HFD, RT-
qPCR on mRNA extracted from whole aortae showed measureable levels of all the genes we
studied, but no difference between EKO and DKOmice. One could criticise these studies for
analysing RNA extracted from the whole tissue, which is composed of smooth muscle and
other cells as well as macrophages. We therefore investigated protein levels in the plaques
directly using quantitative immunocytochemistry. We used the same markers for M1 FCMs
(NOS-2 and COX-2) and M2 FCMs (Arg-1 and Ym-1) that have been validated in previous
studies [16, 30, 67]. Buono and colleagues [29] found no difference in the level of expression of
genes believed to be IFNγ dependent, which is consistent with our findings. Moreover, a num-
ber MMPs and TIMPs were also analysed by immunohistochemistry of plaques. MMP-12 and
MMP-13 were chosen because of the strong genetic and pharmacological evidence for their
involvement in mouse plaque development [34, 68–70]. MMP-14 and TIMP-3 were also stud-
ied because they appear to have opposing roles in pericellular proteolysis in macrophages, and
this results in major effects on macrophage invasion, proliferation and apoptosis [71–73] as
well as collagen degradation [51, 74]. It was also particularly important to measure the protein
levels of MMP-14 and TIMP-3 because post-translational mechanisms control their expression
[71, 72]. All of the antibodies we used gave highly specific staining. It was clear, however, that
T-bet and hence Th1-lymphocytes are dispensable for M1 and M2 polarization of FCMs and
for expression of MMP-12, -13, -14 and TIMP-3 in EKO mice fed a HFD. We also found no
effect of T-bet deletion on M1/M2 polarization, MMP or TIMP-3 expression in the less
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inflammatory model of mice fed a ND for 35 weeks, despite the reduction in plaque size. Our
findings and those of Buono and colleagues [29] are indicative of a systemic rather than local
effect of T-bet deletion on the extent of atherosclerosis in this model.
Summary
In summary, our data clearly show that T-bet knockout can reduce plaque size under ND but
not HFD feeding. However, our main new finding is that M1 macrophage polarization and
related MMP production is preserved or even enhanced in the absence of Th1 lymphocytes on
either diet. The results do not encourage the deployment of strategies designed to reduce Th1
cell activation as treatments against plaque vulnerability but instead favour anti-inflammatory
approaches that directly reverse M1 macrophage polarization.
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